Chesley Bonestell

NCPDP Foundation Opens Its Call for Grant Proposals, Due April 30

Retrieved on: 
Wednesday, February 28, 2024
Innovation, Digital therapeutics, Pharmacogenomics, Social, Pharmacist, Chesley Bonestell, MST, Health, Patient safety, Fund, Medicine, HL7, Trustee, Arrangement, Request, Standard, Value, Role, Single-frequency network, Health equity, Pharmaceutical industry

SCOTTSDALE, Ariz., Feb. 28, 2024 /PRNewswire-PRWeb/ -- The NCPDP Foundation Board of Trustees announced its call for grant proposals that demonstrate the value of NCPDP standards in supporting the expanded role of pharmacists, patient safety, access to care, and coordination of care and innovation. Proposals must meet the grant proposal requirements and be submitted electronically by 5:00 p.m. MST on April 30, 2024, to be considered for the current grant funding cycle.

Key Points: 
  • SCOTTSDALE, Ariz., Feb. 28, 2024 /PRNewswire-PRWeb/ -- The NCPDP Foundation Board of Trustees announced its call for grant proposals that demonstrate the value of NCPDP standards in supporting the expanded role of pharmacists, patient safety, access to care, and coordination of care and innovation.
  • Proposals must meet the grant proposal requirements and be submitted electronically by 5:00 p.m. MST on April 30, 2024, to be considered for the current grant funding cycle.
  • Grant projects must benefit at least one of the NCPDP Foundation strategic initiatives: expanding the role and value of the pharmacist ; expanding patient access to care ; enhancing patient safety ; and empowering coordination of care and innovation, its newest strategic initiative.
  • To submit a grant proposal, complete and submit the Request for Funding form along with supplemental material by 5:00 p.m. MST on April 30, 2024.

NCPDP Foundation Announces its Call for Grant Proposals, Due July 31, 2023

Retrieved on: 
Tuesday, May 23, 2023
Single-frequency network, Standard, Request, Personalized medicine, Social determinants of health, SDOH, Chesley Bonestell, World Telecommunication Standardization Assembly, Pharmacist, Parkinson's Foundation, Digital therapeutics, Trustee, Patient safety, Medicine, Therapy, Pharmaceutical industry, Nursing, Health, NCPDP

SCOTTSDALE, Ariz., May 23, 2023 /PRNewswire-PRWeb/ -- The NCPDP Foundation Board of Trustees announced its call for grant proposals that demonstrate the value of NCPDP standards in supporting patient safety, access to care and the expanded role of pharmacists. Grant proposals must meet the grant proposal requirements and be submitted electronically by July 31, 2023, to be considered for the current grant funding cycle.

Key Points: 
  • Grant proposals must meet the grant proposal requirements and be submitted electronically by July 31, 2023, to be considered for the current grant funding cycle.
  • Research projects must benefit at least one of the NCPDP Foundation strategic initiatives: increasing the role and value of pharmacists; increasing patient access to care; and enhancing patient safety.
  • In addition, research projects must seek to demonstrate and measure how an underutilized NCPDP Standard or a new use for an NCPDP Standard supports the strategic initiative and improves interoperability.
  • While these areas are currently of particular interest, the NCPDP Foundation welcomes and will evaluate other projects that meet the essential criteria.

NCPDP Foundation Announces its Second 2022 Call for Grant Proposals, Due August 18, 2022

Retrieved on: 
Monday, June 6, 2022
Request, Binaytara Foundation, Precision medicine, Single-frequency network, Standard, Research, Pharmacist, Education, Digital, Trustee, Chesley Bonestell, National Council for Prescription Drug Programs, Social determinants of health, National Council, Foundation, Patient safety, Pharmaceutical industry, NCPDP, Health

SCOTTSDALE, Ariz., June 6, 2022 /PRNewswire-PRWeb/ -- The NCPDP Foundation Board of Trustees announced its second 2022 call for grant proposals that demonstrate the value of NCPDP standards in supporting patient safety, access to care and the expanded role of pharmacists. Grant proposals must meet the grant proposal requirements and be submitted electronically by August 18, 2022, to be considered for the current grant funding cycle.

Key Points: 
  • Grant proposals must meet the grant proposal requirements and be submitted electronically by August 18, 2022, to be considered for the current grant funding cycle.
  • In addition, research projects must seek to demonstrate and measure how an underutilized NCPDP Standard or a new use for an NCPDP Standard supports the strategic initiative and improves interoperability.
  • The NCPDP Foundation is a 501(c)(3) nonprofit charitable organization headquartered in Scottsdale, Arizona and is affiliated with the National Council for Prescription Drug Programs (NCPDP).
  • The NCPDP Foundation was established in December 2012 to support research, education, and charitable involvement within the healthcare industry.

Alnylam Publishes 3rd Annual Patient Access Philosophy Report Demonstrating Steady Access to Approved Therapies as Company Enters New Geographies

Retrieved on: 
Tuesday, December 21, 2021
Biotechnology, General Health, Health, Genetics, Pharmaceutical, Genetic testing, Medication, Novartis, Nobel Prize, Nasdaq, Instagram, RNA, Medicine, Patient, Education, Royal commission, Medicaid, LinkedIn, RNA interference, Degenerative disease, CEO, CNS, Medicare, Twitter, Chesley Bonestell, Therapy, Central nervous system, Cost sharing, European Commission, Hope, Science, Pharmaceutical industry, Healthcare, Health insurance, Alnylam Pharmaceuticals

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today published its third annual Patient Access Philosophy Report.

Key Points: 
  • Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today published its third annual Patient Access Philosophy Report.
  • The 2021 Patient Access Philosophy Report summarizes Alnylams latest collaborations with payer, provider, regulatory, distributor, and advocacy partners.
  • This years report also highlights how Alnylam has supported patient access to RNAi therapeutics amidst the ongoing global pandemic.
  • Through these partnerships, Alnylam has:
    Provided access to its therapies to many patients around the world via the establishment of compassionate use and early access programs.

Stellar Health Raises Over $60 Million in Series B Funding Round Led by General Atlantic

Retrieved on: 
Tuesday, September 28, 2021
Software, Practice Management, Finance, General Health, Health, Data Management, Professional Services, Technology, Stellar, Goal, Partnership, Star, Diagnosis, ROI, VBC, Health, Stroke, Medicare, General Atlantic, Engineering, Patient, Fortis Healthcare, ACO, Chesley Bonestell, Industry, CEO, Company, Entrepreneurship, Risk, Male, Documentation, Health care, History, Contract, Autumn, Pharmaceutical industry, Health insurance, Stellar Health, General Atlantic, STELLAR HEALTH, GENERAL ATLANTIC

Stellar Health (Stellar), a leading healthcare technology company, today announced that it has raised over $60 million in Series B funding.

Key Points: 
  • Stellar Health (Stellar), a leading healthcare technology company, today announced that it has raised over $60 million in Series B funding.
  • The funding round was led by General Atlantic, a leading global growth equity firm, with participation from Point72 Ventures and Primary Venture Partners, who led Stellars Series A financing in 2020.
  • Stellars partnership with General Atlantic aims to further accelerate our growth trajectory to expand both internally and externally, and to address workflow evolution.
  • We will continue to evolve our product in ways that will improve the healthcare experience for providers and patients alike.

First Ever Film About "The Father of Space Art" Screens April 2nd at the Smithsonian

Retrieved on: 
Thursday, March 28, 2019
Countries, International organizations, Smithsonian Institution, Chesley Bonestell, Neufeld, Space art, United States, World

Dubbed "The Father of Space Art," Bonestell has been called the world's most influential space artist and credited as quiet force behind the creation of America's space program.

Key Points: 
  • Dubbed "The Father of Space Art," Bonestell has been called the world's most influential space artist and credited as quiet force behind the creation of America's space program.
  • "Having our film presented at The Smithsonian as part of a salute to our country's greatest achievement is an extraordinary honor.
  • Dr. Michael Neufeld, a Senior Curator of the Space History Department at the Smithsonian, will introduce the film.
  • The current issue of Filmfax magazine (#153) features a cover story containing seven pages about the film.

Comic-Con Names 'Chesley Bonestell' Best Documentary

Retrieved on: 
Tuesday, July 31, 2018
Chesley Bonestell, Chesley, Bonestell, San Diego Comic-Con, California, Speculative fiction, Visual arts, English-language films

SAN DIEGO, July 31, 2018 /PRNewswire/ -- The feature-length film Chesley Bonestell: A Brush With The Future has been awarded Best Documentary in this year's 2018 Comic-Con International Independent Film Festival.

Key Points: 
  • SAN DIEGO, July 31, 2018 /PRNewswire/ -- The feature-length film Chesley Bonestell: A Brush With The Future has been awarded Best Documentary in this year's 2018 Comic-Con International Independent Film Festival.
  • The film's producer/writer/director Douglass M. Stewart, Jr. said, "It's an incredible honor just to have the film screened at Comic-Con.
  • To win the award for Best Documentary just takes the whole thing over the top!"
  • The documentary, the first of it kind, chronicles the life of forgotten artist and architect Chesley Bonestell (1888-1986).

'Chesley Bonestell: A Brush With The Future' Chosen As Official Selection For Comic-Con International Film Festival

Retrieved on: 
Tuesday, July 17, 2018
Fiction, Speculative fiction, Science fiction, Space Odyssey series, Chesley Bonestell, English-language films, Chesley, Bonestell, 2001: A Space Odyssey, Craig Barron, Ray Bradbury

SAN DIEGO, July 17, 2018 /PRNewswire/ -- The feature-length documentary Chesley Bonestell: A Brush With The Future has been chosen as an Official Selection for the upcoming 2018 Comic-Con International Film Festival.

Key Points: 
  • SAN DIEGO, July 17, 2018 /PRNewswire/ -- The feature-length documentary Chesley Bonestell: A Brush With The Future has been chosen as an Official Selection for the upcoming 2018 Comic-Con International Film Festival.
  • The documentary, the first of it kind, chronicles the life of forgotten artist and architect Chesley Bonestell (1888-1986).
  • Chesley Bonestell: A Brush With The Future includes rare footage of Bonestell himself and archival perspectives of his work by sci-fi author Ray Bradbury.
  • Also featured are Douglas Trumbull (2001: A Space Odyssey) and Star Wars veterans Ben Burtt, Craig Barron and Richard Edlund.